'2 Doses Safer Now, Will Explore Single Shots Later': AstraZeneca's Plan for Next Stage of Vaccine Trial

AstraZeneca's is looking to test two high doses of its experimental vaccine against the new coronavirus in later stage trials rather than focus on approval for single or lower doses of the vaccine, its biopharma chief said on Monday.

"Right now, the safe thing to do is go with two doses, and then we'll start exploring single doses or lower doses," Mene Pangalos, executive vice-president for BioPharmaceuticals R&D, told reporters